Stay updated on Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page has updated its date information, adding new dates for events in 2025 and 2026 while removing some earlier dates in 2025.
    Difference
    0.6%
    Check dated 2025-05-08T13:06:47.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-05-01T05:25:31.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the removal of detailed descriptions of a phase II clinical trial for treating relapsed follicular lymphoma and diffuse large B-cell lymphoma, while adding new identifiers and collaborators related to the study.
    Difference
    52%
    Check dated 2025-04-16T14:41:23.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4 and has changed the date references from March 25, 2025, to April 1 and April 2, 2025.
    Difference
    0.6%
    Check dated 2025-04-09T09:47:03.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect the latest information on B-cell Lymphoma, with the last update date changed to March 25, 2025, and the revision number updated to v2.14.3. The previous mention of Lymphosarcoma has been removed.
    Difference
    0.5%
    Check dated 2025-04-01T23:35:28.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-25T14:10:43.000Z thumbnail image

Stay in the know with updates to Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rituximab/Pembrolizumab +/- Lenalidomide in Lymphoma Clinical Trial page.